Patient-reported quality-of-life analysis of radium-223 dichloride from the phase III ALSYMPCA study

por Nilsson, S., Cislo, P., Sartor, O., Vogelzang, N. J., Coleman, R. E., O'Sullivan, J. M., Reuning-Scherer, J., Shan, M., Zhan, L., Parker, C.
Publicado 2016